Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Trading Update

7 Jul 2017 07:00

RNS Number : 3743K
Fenner PLC
07 July 2017
 

7 July 2017

Fenner PLC("Fenner" or "the Group")

Trading update

Fenner is providing its customary trading update covering the period from 1 March to 7 July 2017.

The Group has continued to make strong progress, principally in new product development, augmented by a further increase in the US rig count.

Business review

AEP's performance has continued to strengthen across each product area. In particular, our Medical businesses are experiencing strong revenue growth from the development of new customer projects. This provides an encouraging platform for long term growth in line with our plans. In Oil & Gas, the growing order book is now translating into increased sales. Our Industrial businesses are performing ahead of last year, reflecting new product launches.

ECS continues to deliver the planned improvements.

Financing review

Cash flow during the period has remained in line with expectations.

On 1 June, US$90 million of 5.78% Senior Guaranteed Loan Notes matured and, as planned, were repaid at par out of the Group's cash deposits. This will reduce the ongoing interest charge accordingly.

Outlook

Trading across the Group remains positive and, on the basis of the improved outlook, most notably in the medical businesses, the Board anticipates that the Group's operating profit for the financial year ending 31 August 2017 will be comfortably ahead of its previous expectations, with the added benefit of a reduced interest charge going forward.

Financial calendar

The Group expects to release its results for its financial year ending 31 August 2017 on 15 November 2017.

 

For further information please contact:

Fenner PLC

01482 626501

Mark Abrahams, Chief Executive Officer

John Pratt, Group Finance Director

 

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Tom Jenkins

Notes to editors:

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Advanced Engineered Products: The AEP division is a group of nine businesses that use advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems across a variety of markets, generally classified as specialist industrial, medical and oil & gas. AEP's trading names include Hallite, Fenner Precision, Fenner Drives, Secant Group, Charter Medical, CDI Energy Products and EGC Critical Components.

Engineered Conveyor Solutions: The ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is an established global leader in the supply of heavyweight conveyor belting and related services to the mining, industrial and bulk materials markets. ECS has leading presences in the Northern Hemisphere (principally North America and Europe) and the Southern Hemisphere (principally Australia).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDSIRIID
Date   Source Headline
19th Aug 20147:00 amRNSDirectorate Change
6th Aug 20142:13 pmRNSDirector/PDMR Shareholding
6th Aug 201410:33 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSInterim Management Statement
30th Jun 20143:06 pmRNSHolding(s) in Company
20th Jun 201412:40 pmRNSHolding(s) in Company
12th Jun 20147:00 amRNSCapital Markets Event
6th Jun 201411:20 amRNSDirector/PDMR Shareholding
5th Jun 20141:43 pmRNSDirector/PDMR Shareholding
30th May 20147:00 amRNSTrading Update
24th Apr 20144:10 pmRNSHolding(s) in Company
23rd Apr 20147:00 amRNSHalf Yearly Report
15th Apr 201412:17 pmRNSHolding(s) in Company
2nd Apr 20142:02 pmRNSHolding(s) in Company
13th Mar 20149:34 amRNSHolding(s) in Company
11th Mar 20147:00 amRNSPre-Close Trading Statement
5th Mar 20143:47 pmRNSHolding(s) in Company
3rd Mar 201410:49 amRNSBlocklisting Interim Review
20th Feb 20142:47 pmRNSHolding(s) in Company
4th Feb 20149:59 amRNSDirector/PDMR Shareholding
31st Jan 201412:28 pmRNSHolding(s) in Company
24th Jan 20142:40 pmRNSHolding(s) in Company
23rd Jan 201412:21 pmRNSHolding(s) in Company
17th Jan 20141:36 pmRNSResult of AGM
15th Jan 20147:00 amRNSInterim Management Statement
12th Dec 201310:49 amRNSDocuments Available for Inspection/Notice of AGM
29th Nov 20139:24 amRNSTotal Voting Rights
25th Nov 20139:16 amRNSDirector/PDMR Shareholding
21st Nov 20133:39 pmRNSDirector/PDMR Shareholding
14th Nov 201311:27 amRNSAdditional Listing
13th Nov 201310:15 amRNSAmendment
13th Nov 20137:00 amRNSFinal Results
8th Nov 20132:25 pmRNSHolding(s) in Company
21st Oct 20132:35 pmRNSHolding(s) in Company
27th Sep 20132:38 pmRNSHolding(s) in Company
10th Sep 20137:00 amRNSPre-close Trading Statement
2nd Sep 20132:01 pmRNSBlocklisting Interim Review
28th Aug 201311:35 amRNSHolding(s) in Company
22nd Aug 201312:16 pmRNSHolding(s) in Company
7th Aug 20134:35 pmRNSHolding(s) in Company
31st Jul 201312:38 pmRNSHolding(s) in Company
18th Jul 20137:00 amRNSInterim Management Statement
10th Jul 20139:21 amRNSHolding(s) in Company
9th Jul 20132:10 pmRNSHolding(s) in Company
5th Jul 20133:14 pmRNSHolding(s) in Company
21st Jun 201310:05 amRNSDirector/PDMR Shareholding
10th Jun 201310:50 amRNSDirector/PDMR Shareholding
5th Jun 201310:55 amRNSDirector/PDMR Shareholding
30th May 20132:33 pmRNSDirector/PDMR Shareholding
24th May 20133:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.